WEIBO Corp: Form 20-F for the period ended Dec 31, 2020
Filed with the SEC on Apr 22, 2021 and accepted by EDGAR at Apr 22, 2021, 06:56 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2020-01-01 to 2020-12-31 | $1.69bn | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Cost of revenue | 12 months2020-01-01 to 2020-12-31 | $302.2m | us-gaap:CostOfGoodsAndServicesSold |
| Research and development | 12 months2020-01-01 to 2020-12-31 | $324.1m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2020-01-01 to 2020-12-31 | $506.8m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2020-01-01 to 2020-12-31 | $57.4m | us-gaap:InterestExpense |
| Income tax | 12 months2020-01-01 to 2020-12-31 | $61.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2020-01-01 to 2020-12-31 | $313.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2020-01-01 to 2020-12-31 | $1.38 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2020-01-01 to 2020-12-31 | $1.38 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2020-01-01 to 2020-12-31 | 227,637,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2020-01-01 to 2020-12-31 | $741.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2020-01-01 to 2020-12-31 | $34.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2020-12-31 | $1.81bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2020-12-31 | $4.83bn | us-gaap:AssetsCurrent |
| Total assets | At period end2020-12-31 | $6.34bn | us-gaap:Assets |
| Current liabilities | At period end2020-12-31 | $958.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2020-12-31 | $3.45bn | us-gaap:Liabilities |
| Shareholders' equity | At period end2020-12-31 | $2.81bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001104659-21-053395. Last ingested by Listed: Oct 28, 2026, 07:35 ET. Listed shows no prices and gives no investment advice.